Common antibiotics are struggling to fight “superbugs” at healthcare facilities, in Europe.

Researchers at the World Health Organisation (WHO) released statistics this week, alongside the European Centre for Disease Prevention and Control (ECDC), after analysing progress on targets to reduce infections caused by “superbugs.”

In the case of an attempt to reduce a common hospital bacterium known as Klebsiella pneumoniae, by at least 5%, infections rocketed to a staggering 72%, between 2019 and 2025.

Where patients were infected with E. coli bacterium, also resistant to regular antibiotics, known as cephalosporins, cases increased by at least 16%.

WHO said that it found resistance to key antibiotics in at least half of the samples of Klebsiella pneumoniae and another common bug, Acinetobacter, in about one in two countries in Europe.

Dr Marc-Alain Widdowson, head of health security at WHO in Europe, said “in many countries in the region, the antibiotics doctors usually reach for first, are failing against serious hospital infections.”

He also said “when these treatments fail to work, doctors turn to stronger drugs normally kept for the most serious cases that are called carbapenems.”

WHO noted that of 51 countries analysed, 16 still lack a standardized national approach and national coordination, hampering the effort to overcome antimicrobial resistance globally. 

Picture: University of Virginia

Leave a Reply

Your email address will not be published. Required fields are marked *